---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-261698"
form_type: "8-K"
ticker: "KYMR"
cik: "0001815442"
company_name: "Kymera Therapeutics, Inc."
filed_at: "2026-06-08T20:05:07+00:00"
generated_at: "2026-06-08T20:11:57.902444+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Kymera Therapeutics COO Jeremy Chadwick resigns effective June 5, 2026; will advise through Nov 2026

## Summary
- COO Jeremy Chadwick resigned for personal reasons, not due to any disagreement with company policies.
- Chadwick will remain as an employee advisor until November 2026.
- No replacement COO has been named by the company.
- Chadwick communicated his intention to retire and submitted resignation on June 5, 2026.

## SEC filing metadata
- accession: 0001193125-26-261698
- form_type: 8-K
- ticker: KYMR
- cik: 0001815442
- company_name: Kymera Therapeutics, Inc.
- filed_at: 2026-06-08T20:05:07+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815442/000119312526261698/0001193125-26-261698-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815442/000119312526261698/d13635d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-261698
- JSON: https://secwatch.observer/filing/0001193125-26-261698.json
- Plain text: https://secwatch.observer/filing/0001193125-26-261698.txt

## Key facts
- Executive change
  Jeremy Chadwick resigned as Chief Operating Officer at Kymera Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Operating Officer
  source text: Jeremy Chadwick communicated his intention to retire and submitted his resignation as Chief Operating Officer (“COO”) on June 5, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815442/000119312526261698/0001193125-26-261698-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.